Cartesian Therapeutics Inc - RNAC - stock price prediction, stock price target, analyst ratings from 8 analysts

Cartesian Therapeutics Inc has a share price target of US$ 35, revenue growth forecast of -80.4%, and profit growth estimate of 6.1% for FY26, based on top 8 analyst calls.